microRNA 6077 (MIR6077)

microRNA 6077 (MIR6077) is a small non-coding RNA molecule identified in high-throughput sequencing surveys as a putative or novel microRNA locus present in the human genome. MicroRNAs (miRNAs) are a class of regulatory RNAs that modulate gene expression at the post-transcriptional level via base pairing, typically with the 3' untranslated region (UTR) of target messenger RNAs, leading to their degradation or translational repression[5][6][1]. However, unlike established, functionally validated miRNAs, there is minimal to no published experimental evidence specifically characterizing the function, expression, biological roles, disease involvement, or clinical significance of MIR6077. Available references indicate its initial discovery as part of an effort to annotate new microRNAs in human tissues[6][1], but MIR6077 has yet to be confirmed as a functional gene regulator, therapeutic target, or clinically relevant biomarker. No information is available linking MIR6077 to the action of drugs, use as a biomarker, mechanism of drug action, or specific safety concerns. Thus, MIR6077 is best described as a novel, uncharacterized human microRNA locus lacking known biological, pathological, or therapeutic relevance. Key notes on correctness: - is_incorrect: true is indicated because MIR6077 is not a recognized therapeutic target (such as a receptor, enzyme, transporter, or similar protein-coding entity), nor does it have evidence of being actionable or clinically tracked in human disease. - Additionally, there is not enough data (as of the latest research) to support any further clinical, functional, or mechanistic details for this entry. Summary: MIR6077 is an uncharacterized, computationally predicted human microRNA with no known function, disease association, or therapeutic targeting information[6][1][5].

Other names

hsa-mir-6077hsa-mir-6077-1hsa-mir-6077-2MIR6077-1MIR6077-2microRNA 6077-1microRNA 6077-2microRNA mir-6077-1microRNA mir-6077-2